Biblioteca Humberto Rosselli Quijano
Información del autor
Autor Jose M. Martínez |
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
Efficacy of open-label nefazodone treatment in patients with panic disorder / Laszlo A. Papp en Journal of Clinical Psychopharmacology, Año 2000 - Vol. 20 - No. 5 (Octubre)
[artículo]
Título : Efficacy of open-label nefazodone treatment in patients with panic disorder Tipo de documento: texto impreso Autores: Laszlo A. Papp, Autor ; Jeremy D. Coplan, Autor ; Jose M. Martínez, Autor Fecha de publicación: 2023 Artículo en la página: pp. 544-546 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Antidepresivos de segunda generación, Trastorno de pánico, Piperazinas, Triazoles. Resumen: Fifteen patients with panic disorder participated in a 12-week treatment trial with open-label nefazodone. Nefazodone was well-tolerated with minimal side effects; none of the patients reported sexual dysfunction, and only one patient experienced weight gain. Although the response rate was lower than that found with most other antipanic medications, given its favorable side effect profile, nefazodone may be a good alternative for patients apprehensive about potential adverse drug reactions. Link: ./index.php?lvl=notice_display&id=31169
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 544-546[artículo] Efficacy of open-label nefazodone treatment in patients with panic disorder [texto impreso] / Laszlo A. Papp, Autor ; Jeremy D. Coplan, Autor ; Jose M. Martínez, Autor . - 2023 . - pp. 544-546.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 5 (Octubre) . - pp. 544-546
Palabras clave: Antidepresivos de segunda generación, Trastorno de pánico, Piperazinas, Triazoles. Resumen: Fifteen patients with panic disorder participated in a 12-week treatment trial with open-label nefazodone. Nefazodone was well-tolerated with minimal side effects; none of the patients reported sexual dysfunction, and only one patient experienced weight gain. Although the response rate was lower than that found with most other antipanic medications, given its favorable side effect profile, nefazodone may be a good alternative for patients apprehensive about potential adverse drug reactions. Link: ./index.php?lvl=notice_display&id=31169